IDRI Announces Appointment of Dr. Karen Auditore-Hargreaves as SVP, Scientific Affairs
...P. Perry, President and Chief Executive Officer of anacor Pharmaceuticals, Inc., have been appointed to IDRI...sit www.bvgh.org . David Perry has served as anacor Pharmaceuticals' President and Chief Executive Off...member of its board of directors since April 2002. anacor Pharmaceuticals is a biopharmaceutical company dev...Study Lets Teens Sound Off on Acne Therapies
...Zane has participated on advisory boards for Connetics Corp., Stiefel Laboratories Inc., Medicis Pharmaceutical Corp., and QLT Inc., and now works for anacor Pharmaceuticals Inc. These types of patient questionnaires can help improve patient care, Dr. Marta J. VanBeek, of the University of Iowa Hospitals...Biotech Finishes on a High in August, Burrill Report Says
...gned and optimized using PROfusion, the company's patented protein design engine that enables rapid optimization of protein therapeutics. -- anacor Pharmaceuticals, which is developing novel small-molecule therapeutics derived from boron chemistry. The company has focused initially on dev...Researchers Devise New Compound to Treat Fungal Infections
...l for the protein synthesis of fungal pathogens. The study was conducted by a team of researchers including Dickon Alley and Stephen Cusack at anacor Pharmaceuticals Inc., California, and the European Molecular Biology Laboratory (EMBL) outstation in Grenoble, France. AN2690 interferes with a...Anacor Clinical Study of AN2728, a Novel Anti-Inflammatory Compound, Shows Efficacy in Psoriasis
...ing skin condition that may be associated with disabling arthritis. About anacor Pharmaceuticals Anacor, a privately held, clinical-stage pharmaceutical c...-739-0700; or Brian Reid of WeissComm Partners, Inc.,+1-703-402-3626, , for anacor PharmaceuticalsInc. anacor received a $40 million upfront payment and a $10 m...anti-fungal properties during preclinical testing. anacor researchers and collaborators from the European Mo...2009 Pharma ChemOutsourcing Show Attendance Up an Astounding 60% Despite Current Recession
...s, Proteolix, Novalar Pharmaceuticals, Lexicon Pharmaceuticals, Orexigen Therapeutics, Targacept, Helsinn Therapeutics, OSI Prosidion, NovaDel Pharma, anacor Pharmaceuticals, Ceragenix, Millennium Pharmaceuticals (Takeda), Pharmasset, Oscient Pharmaceuticals, Cenomed Biosciences, Alkermes, Epix Pharmaceutic...Anacor Achieves Milestone from GSK for Boron-Based Systemic Antibacterial Product Candidate
... PALO ALTO, Calif., Jan. 12 /PRNewswire/ -- anacor Pharmaceuticals today announced that it has achiev... from its collaboration partner, GlaxoSmithKline. anacor may receive future milestone payments and royaltie...novel product candidates." In October 2007, anacor and GlaxoSmithKline announced a worldwide strategi...Anacor Raises $50 Million in Equity Financing
... PALO ALTO, Calif., Jan. 6 /PRNewswire/ -- anacor Pharmaceuticals today announced that it has raised...orm," said David Perry, Chief Executive Officer at anacor Pharmaceuticals. The investments from GSK a...cent of Anacor's outstanding shares. About anacor Pharmaceuticals ...Sangamo BioSciences Appoints Paul Cleveland to Its Board of Directors and Chair of Audit Committee
...odward LLP, Sidley Austin LLP and Davis Polk & Wardwell. He serves as a member of the board of directors and is chairman of the audit committee of anacor Pharmaceuticals, Inc. Mr. Cleveland holds a J.D. from Northwestern University School of Law and an A.B. from Washington University in St. Louis. ...Anacor Pharmaceuticals Appoints Dr. Kurt Jarnagin Vice President of Biological Research
... PALO ALTO, Calif., Aug. 4 /PRNewswire/ -- anacor Pharmaceuticals announced today that it has appoin...ttner, Ph.D., Senior Vice President of Research at anacor Pharmaceuticals. "Kurt is a noted expert in the fi...orth Carolina State University in Raleigh. About anacor Pharmaceuticals ...Lucy Shapiro, Ph.D., Elected to Gen-Probe Board of Directors
...ernational Studies at Stanford and a fellow of the American Association for the Advancement of Sciences. Dr. Shapiro is a co-founder and director of anacor Pharmaceuticals, a biopharmaceutical company developing novel small-molecule therapeutics to treat infectious and inflammatory diseases. She is also c...Anacor Files Registration Statement for Initial Public Offering
... PALO ALTO, Calif., Aug. 31 /PRNewswire/ -- anacor Pharmaceuticals announced today that it has filed ...nder the securities laws of any such state. About anacor Pharmaceuticals anacor is a biopharmaceutical company developing novel sm...